Wielding more power over angiogenesis.
Habeck
M
M
D043925:Angiogenesis Inducing Agents / Q000378:metabolism* / Q000494:pharmacology; D020533:Angiogenesis Inhibitors / Q000378:metabolism* / Q000494:pharmacology; D000818:Animals; D023181:Antimicrobial Cationic Peptides; D003094:Collagen / Q000378:metabolism* / Q000494:pharmacology; D004268:DNA-Binding Proteins / Q000378:metabolism; D004730:Endothelium, Vascular / Q000166:cytology; D051793:Hypoxia-Inducible Factor 1; D051795:Hypoxia-Inducible Factor 1, alpha Subunit; D051379:Mice; D009389:Neovascularization, Pathologic; D009687:Nuclear Proteins / Q000378:metabolism; D010455:Peptides / Q000378:metabolism* / Q000494:pharmacology; D017468:Receptors, Fibroblast Growth Factor / Q000378:metabolism; D014157:Transcription Factors
D043925:Angiogenesis Inducing Agents; D020533:Angiogenesis Inhibitors; D023181:Antimicrobial Cationic Peptides; D004268:DNA-Binding Proteins; C497443:Hif1a protein, mouse; D051793:Hypoxia-Inducible Factor 1; D051795:Hypoxia-Inducible Factor 1, alpha Subunit; D009687:Nuclear Proteins; D010455:Peptides; D017468:Receptors, Fibroblast Growth Factor; D014157:Transcription Factors; C072212:PR 39; D003094:Collagen